Hortensia Gimeno1, Kylee Tustin2, Daniel Lumsden3, Keyoumars Ashkan4, Richard Selway4, Jean-Pierre Lin2. 1. Complex Motor Disorders Service, Evelina London Children's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK; King's Health Partners Academic Health Sciences Centre, London, UK. Electronic address: hortensia.gimeno@gstt.nhs.uk. 2. Complex Motor Disorders Service, Evelina London Children's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK; King's Health Partners Academic Health Sciences Centre, London, UK. 3. Complex Motor Disorders Service, Evelina London Children's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK. 4. King's Health Partners Academic Health Sciences Centre, London, UK; Functional Neurosurgery Department, King's College Hospital, London, UK.
Abstract
PURPOSE: To evaluate the functional goal-directed outcomes of Deep Brain Stimulation (DBS) in childhood dystonia according to aetiology and to explore relationship with a traditional impairment-based measure. METHOD: This is a prospective case series study involving thirty children with dystonia with a 1-year follow-up post-DBS. The Canadian Occupational Performance Measure (COPM) and Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) were used as primary outcome measures. Results were analysed based on aetiology in 3 groups: 1. primary/primary plus dystonia; 2. secondary dystonia-cerebral palsy (CP); 3. secondary dystonia-non-CP group. Correlation between functional outcome using COPM and dystonia improvement as captured by BFMDRS was measured. RESULTS: All groups demonstrated significant improvement in individualised goal attainment, measured with the COPM, at 1-year post-DBS. The secondary dystonia-CP group also achieved significant improvement at 6 months for performance and satisfaction scores. In the majority of secondary dystonias, the BFMDRS failed to demonstrate significant improvement. A linear correlation between change in BFMDRS and COPM scores was observed when the entire cohort was analysed. INTERPRETATION/ CONCLUSIONS: DBS improved functional performance, independently of the dystonic phenotype. Improvements in individualized COPM functional goal areas were seen in the absence of significant changes in BFMDRS scores, highlighting the relative insensitivity of impairment scales in this patient group.
PURPOSE: To evaluate the functional goal-directed outcomes of Deep Brain Stimulation (DBS) in childhood dystonia according to aetiology and to explore relationship with a traditional impairment-based measure. METHOD: This is a prospective case series study involving thirty children with dystonia with a 1-year follow-up post-DBS. The Canadian Occupational Performance Measure (COPM) and Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) were used as primary outcome measures. Results were analysed based on aetiology in 3 groups: 1. primary/primary plus dystonia; 2. secondary dystonia-cerebral palsy (CP); 3. secondary dystonia-non-CP group. Correlation between functional outcome using COPM and dystonia improvement as captured by BFMDRS was measured. RESULTS: All groups demonstrated significant improvement in individualised goal attainment, measured with the COPM, at 1-year post-DBS. The secondary dystonia-CP group also achieved significant improvement at 6 months for performance and satisfaction scores. In the majority of secondary dystonias, the BFMDRS failed to demonstrate significant improvement. A linear correlation between change in BFMDRS and COPM scores was observed when the entire cohort was analysed. INTERPRETATION/ CONCLUSIONS: DBS improved functional performance, independently of the dystonic phenotype. Improvements in individualized COPM functional goal areas were seen in the absence of significant changes in BFMDRS scores, highlighting the relative insensitivity of impairment scales in this patient group.
Authors: Aysegul Gunduz; Hokuto Morita; P Justin Rossi; William L Allen; Ron L Alterman; Helen Bronte-Stewart; Christopher R Butson; David Charles; Sjaak Deckers; Coralie de Hemptinne; Mahlon DeLong; Darin Dougherty; Jens Ellrich; Kelly D Foote; James Giordano; Wayne Goodman; Benjamin D Greenberg; David Greene; Robert Gross; Jack W Judy; Edward Karst; Alexander Kent; Brian Kopell; Anthony Lang; Andres Lozano; Codrin Lungu; Kelly E Lyons; Andre Machado; Hubert Martens; Cameron McIntyre; Hoon-Ki Min; Joseph Neimat; Jill Ostrem; Sat Pannu; Francisco Ponce; Nader Pouratian; Donnie Reymers; Lauren Schrock; Sameer Sheth; Ludy Shih; Scott Stanslaski; G Karl Steinke; Paul Stypulkowski; Alexander I Tröster; Leo Verhagen; Harrison Walker; Michael S Okun Journal: Int J Neurosci Date: 2015-05-25 Impact factor: 2.292
Authors: Verity M McClelland; Doreen Fialho; Denise Flexney-Briscoe; Graham E Holder; Markus C Elze; Hortensia Gimeno; Ata Siddiqui; Kerry Mills; Richard Selway; Jean-Pierre Lin Journal: Clin Neurophysiol Date: 2017-11-24 Impact factor: 3.708
Authors: Helga Haberfehlner; Marije Goudriaan; Laura A Bonouvrié; Elise P Jansma; Jaap Harlaar; R Jeroen Vermeulen; Marjolein M van der Krogt; Annemieke I Buizer Journal: J Neuroeng Rehabil Date: 2020-03-05 Impact factor: 4.262
Authors: Corina N A M van den Heuvel; Marina A J Tijssen; Bart P C van de Warrenburg; Cathérine C S Delnooz Journal: Mov Disord Clin Pract Date: 2016-08-03
Authors: Marenka Smit; Alberto Albanese; Monika Benson; Mark J Edwards; Holm Graessner; Michael Hutchinson; Robert Jech; Joachim K Krauss; Francesca Morgante; Belen Pérez Dueñas; Richard B Reilly; Michele Tinazzi; Maria Fiorella Contarino; Marina A J Tijssen Journal: Front Neurol Date: 2021-06-03 Impact factor: 4.003
Authors: Katrina A MuÑoz; Jennifer Blumenthal-Barby; Eric A Storch; Laura Torgerson; Gabriel LÁzaro-MuÑoz Journal: Camb Q Healthc Ethics Date: 2020-10 Impact factor: 1.566
Authors: Hendriekje Eggink; Rivka F Toonen; Jonathan C van Zijl; Martje E van Egmond; Anna L Bartels; Rick Brandsma; M Fiorella Contarino; Kathryn J Peall; J Marc C van Dijk; D L Marinus Oterdoom; Martijn Beudel; Marina A J Tijssen Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2020-06-08
Authors: Laura A Bonouvrié; Jules G Becher; Johan S H Vles; R Jeroen Vermeulen; Annemieke I Buizer Journal: Ann Neurol Date: 2019-05-21 Impact factor: 10.422